The Future of Agriculture
Welcome to the Future of Agriculture and learn how biotechnology and agriculture are helping to shape the way for a sustainable future.
BARDA, Department of Defense, and SAb Biotherapeutics to Partner to Develop a Novel COVID-19 Therapeutic
Published by Medical Counter Measures
A therapeutic to treat novel coronavirus disease 2019 (COVID-19) is moving forward in development through a partnership between BARDA, the Department of Defense Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO – CBRND), and SAb Biotherapeutics, Inc. (SAb), of Sioux Falls, South Dakota.
Using an interagency agreement with JPEO’s Medical CBRN Defense Consortium, BARDA transferred approximately $7.2 million in funding to (JPEO – CBRND) to support SAb to complete manufacturing and preclinical studies, with an option to conduct a Phase 1 clinical trial.
Bovine plasma donors genetically engineered to produce human antibodies are in the front lines of the struggle against coronavirus.
SAB Biotherapeutics, a Sioux Falls, S.D., biotechnology company that has been successfully testing use of antibodies from cows to fight diseases such as another coronavirus, Middle East respiratory syndrome, now is engaged in developing a treatment for COVID-19, the disease caused by the novel coronavirus.
Maple sugaring is as traditional an activity as you can find, but for commercial operations, tradition is increasingly being replaced by technological improvements in a battle against modern climate obstacles.
“If you just wait until town meeting day, like they used to do, you’ll miss half the season. You can’t do that too many years or you’ll go under,” said Jeff Moore, whose family runs Windswept Maples farm in Loudon. “We’ve got to be ready, able to gather sap whenever it runs.”